Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ambrx
Biotech
J&J hooks Proteologix for at least $850M in cash
J&J's proposed purchase is the pharma's second biotech buy of the year after scooping up Ambrx.
Max Bayer
May 16, 2024 10:12am
J&J sees ‘opportunities’ in neuro and immunology post-Ambrx buy
Jan 23, 2024 10:54am
J&J beefs up ADC pipeline by acquiring Ambrx for $2B
Jan 8, 2024 8:25am
Ambrx's 'reset' arrives at the last line of prostate cancer
Oct 22, 2023 9:39am
FDA's Peter Marks doesn't plan to retire soon—Chutes & Ladders
Aug 4, 2023 9:30am
New Ambrx CEO spies a path for ousted breast cancer med
Mar 1, 2023 11:20am
